Search
Now showing items 1-1 of 1
Hearing loss in patients receiving cisplatin at Uganda Cancer Institute.
(Makerere University, 2012-06)
Introduction.
Cisplatin (cis-diamminedichloridoplatinum) is an antineoplastic agent with ototoxic effects (1-7). Cisplatin-induced ototoxicity is manifested as high – frequency sensorineural hearing loss (SNHL). Audiologic ...